O
Osman Ozan Yeğit
Researcher at Istanbul University
Publications - 10
Citations - 21
Osman Ozan Yeğit is an academic researcher from Istanbul University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications receiving 3 citations.
Papers
More filters
Journal ArticleDOI
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency.
Deniz Eyice Karabacak,Semra Demir,Osman Ozan Yeğit,Ali Can,Kadriye Terzioğlu,Derya Unal,Muge Olgac,Raif Coskun,Bahauddin Colakoglu,Suna Büyüköztürk,Aslı Gelincik +10 more
TL;DR: In this paper, the effects of anxiety, depression and stress related to COVID-19 pandemic on disease activity of HAE patients during the quarantine period (QP) and the return to normal period (RTNP).
Journal ArticleDOI
Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic.
Osman Ozan Yeğit,Semra Demir,Derya Unal,Muge Olgac,Kadriye Terzioğlu,Deniz Eyice Karabacak,Can Tüzer,Vehbi Ayhan,Bahattin Çolakoğlu,Suna Büyüköztürk,Aslı Gelincik +10 more
TL;DR: In this paper, the authors investigated adherence to SCIT with aeroallergens during the COVID-19 pandemic and demonstrate clinical consequences of treatment disruptions in real life.
Journal ArticleDOI
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance.
Ali Can,Raif Coskun,Deniz Eyice Karabacak,Osman Ozan Yeğit,Pelin Karadag,Nida Oztop,Sengul Beyaz,Gulfer Okumus,Semra Demir,Aslı Gelincik +9 more
TL;DR: In this article , the authors evaluated the sleep attitude and circadian rhythm in patients with chronic spontaneous urticaria (CSU) with sleep disturbance in studies that involve a large number of patients.
Journal ArticleDOI
Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study
TL;DR: In this article , the authors evaluated the response to omalizumab treatment in patients with chronic spontaneous urticaria (CSU) and symptomatic dermographism (SDerm).
Journal ArticleDOI
Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study.
TL;DR: In this paper , clinical features and laboratory data were compared between groups of patients with severe eosinophilic asthma who were classified as super-responders, partial responders, or nonresponders to mepolizumab treatment.